Skip to main content
Caplight Logo









Sword Bio

Sword Bio

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://swordbio.com

Last Round

Seed

Jun 26, 2025

Est. Valuation

$11.7M

Total Funding Raised

$1.7M

Company Overview

Sword Bio operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Pre Seed round in June 2023.

Sword Bio is a biotechnology company that operates as a bioanalytical contract research organization (CRO) providing assay development, validation, and sample analysis services to support pharmaceutical and biotech companies in drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Sword Bio Comparables

Compare Sword Bio with similar companies based on industry and business-model similarity.

Sword Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NorthEast BioAnalytical Laboratories LLC
88%
Meadowhawk Biolabs, Inc.
85%
Alturas Analytics, Inc.
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Sword Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 26, 2025
Pre SeedJun 26, 2023
Series BMar 5, 2007
Series AOct 13, 2006
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Matthew Langevin

COO

Executive Team

For institutional investors. Book with your work email.

Sword Bio Investors

Notable investors and investment history

Sword Bio investors
InvestorRounds
Jumpstart NJ Angel NetworkAngel, Pre Seed
Keiretsu ForumAngel, Pre Seed
Elevate VenturesAngel, Pre Seed
Tech Council VenturesAngel, Pre Seed, Series A, Series B
Heartland AngelsAngel, Pre Seed
Angel Physicians FundPre Seed
Calvert Research and ManagementSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2025

    $4M raised in Seed round.

  • Jun 26, 2023

    $50K round from Elevate Ventures and Tech Council Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withOct 26, 2026

    Sword Bio Limited and Alturas Analytics announce a strategic collaboration designed to provide biotechnology and pharmaceutical companies with coordinated access to complementary bioanalytical capabilities across large- and small-molecule drug development in Idaho on Oct 26th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Sword Bio Filings

Explore SEC and related filing metadata, where available.

Sword Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Sword Bio's valuation, stock price, and market status.

Is Sword Bio a public or private company?

Sword Bio is a private company.

What is the current stock price of Sword Bio?

Sword Bio is a private company, so its shares have no public market price. Caplight tracks Sword Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Sword Bio worth (valuation)?

Sword Bio's valuation is estimated at $11.7M based on funding round data.

Can I buy Sword Bio stock?

Sword Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Sword Bio's last funding round?

Sword Bio's most recent funding round was Seed on June 26, 2025.

Who are the main investors in Sword Bio?

Key investors in Sword Bio include Jumpstart NJ Angel Network, Keiretsu Forum, Elevate Ventures, Tech Council Ventures, Heartland Angels.

Will Sword Bio IPO soon?

No public IPO plans have been announced for Sword Bio.

How can I track Sword Bio secondary market activity?

Caplight tracks bids, offers, and trades in Sword Bio's shares on secondary markets.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range21
Year Founded2005
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?